Exploring The Right Dose Of Magic Mushrooms

Hallucinogenic mushrooms, also known as magic mushrooms, are fungi that contain hallucinogenic compounds, most commonly psilocybin and psilocin. The effects of magic mushrooms vary from person to person and can include hallucinations, an altered state of consciousness, anxiety, fear, nausea, and muscle twitches. The strength of magic mushrooms can also vary, depending on the dose and type of mushroom used. While the use of magic mushrooms has been associated with negative consequences such as bad trips and flashbacks, there is increasing interest in their potential therapeutic benefits, particularly in the treatment of mental health disorders. The legality of magic mushrooms varies across different countries and regions, with some classifying them as controlled substances and others considering the intent of possession or sale.

History of hallucinogenic mushrooms

Hallucinogenic mushrooms, also known as psilocybin mushrooms, magic mushrooms, or shrooms, have a long and fascinating history that dates back thousands of years. Here is an overview of the history of hallucinogenic mushrooms:

Ancient History

The use of hallucinogenic mushrooms has a long history, possibly dating back millions of years. Early hominins were believed to have consumed mushrooms as part of their diet, and there is evidence suggesting that psychedelic mushrooms played a role in their evolution. This idea is supported by the presence of mycophagy (mushroom consumption) and self-medication practices observed in both primates and Paleolithic humans. The earliest known depiction of hallucinogenic mushroom use is believed to be a 4000 BCE cave painting in Spain, which illustrates what appear to be Psilocybe hispanica mushrooms, known for their hallucinogenic properties.

Mesoamerican Civilizations

Hallucinogenic mushrooms have a rich history in Mesoamerican civilizations such as the Aztecs and their predecessors. The Aztecs referred to these mushrooms as "teonanacatl," meaning "god's flesh" or divine mushroom. They were used in religious rituals, healing practices, and divination. A statuette from around 200 CE found in western Mexico depicts a mushroom resembling Psilocybe mexicana, indicating the significance of these fungi in ancient Mesoamerican cultures.

Persecution and Suppression

With the arrival of Spanish conquistadors and missionaries in the 1500s, the use of hallucinogenic mushrooms by indigenous peoples was persecuted and suppressed. The Spanish associated the mushrooms with idolatry and believed they allowed communication with demons. Spanish missionaries attempted to destroy all records and evidence of mushroom use, but some references survived in the writings of a 16th-century friar, intriguing later ethnopharmacologists. Despite the suppression, the use of hallucinogenic mushrooms persisted in remote areas, and they continued to play a role in the cultural traditions of indigenous communities.

Modern Exploration and Research

In the late 1950s, Swiss chemist Albert Hofmann isolated psilocybin and psilocin from Psilocybe mexicana mushrooms. This discovery led to further exploration and synthesis of these compounds, with Hofmann's employer, Sandoz, marketing and selling pure psilocybin for use in psychedelic therapy worldwide. However, increasing drug restrictions in the 1960s and 1970s curbed scientific research into psilocybin and other hallucinogens. Despite this, interest in the therapeutic potential of hallucinogenic mushrooms has persisted, and they are now being studied for the treatment of various psychiatric disorders.

Today, hallucinogenic mushrooms continue to be a subject of fascination and research, with ongoing exploration into their therapeutic benefits and evolutionary history. Their use remains controversial, but there is a growing recognition of their potential medicinal value, contributing to a complex and evolving history that spans millennia.

Effects of hallucinogenic mushrooms

The effects of hallucinogenic mushrooms, also known as magic mushrooms, usually begin within 15 to 45 minutes of ingestion and can last for four to six hours. The duration of the effects depends on the method of consumption, with eating the mushrooms taking around 30 minutes for the effects to kick in, while consuming them as a soup or tea reduces this time to 5–10 minutes.

The primary active ingredients in magic mushrooms are psilocybin and psilocin, which are hallucinogens that produce effects similar to LSD. These substances bind to and activate serotonin receptors in parts of the brain that affect mood, cognition, and perception, such as the prefrontal cortex and amygdala. This leads to perceptual changes, including visual and auditory hallucinations, an altered perception of time and space, and distorted emotions and perception.

The psychological consequences of consuming hallucinogenic mushrooms can vary depending on the individual's mood, prior encounters with psychedelic drugs, and expectations. A positive state of mind, a comfortable and familiar environment, and the presence of trusted friends can contribute to a pleasant experience. On the other hand, feelings of stress or anxiety, or being in a negative environment can increase the risk of a ""bad trip,"" which may include heightened anxiety, panic reactions, and psychosis.

While physical dependence on magic mushrooms is rare, regular users may develop tolerance, requiring higher doses to achieve the desired effects. Additionally, some individuals may experience flashbacks or hallucinations involving previous mushroom experiences, which can be disturbing and distressing. These flashbacks can occur weeks, months, or even years after the initial drug use and are known as hallucinogen-persisting perception disorder, a rare condition.

It is important to note that the use of magic mushrooms carries risks, and they should not be consumed by individuals taking certain medications or with particular mental health conditions. Mixing magic mushrooms with other drugs can also increase the chances of a bad trip and lead to unpredictable and dangerous consequences. Furthermore, there is a risk of accidental poisoning from consuming poisonous mushrooms, which may result in severe gastrointestinal illness or, in rare cases, fatal events due to emotional distress and trip-induced psychosis.

Therapeutic uses of hallucinogenic mushrooms

Psilocybin, a hallucinogenic chemical found in certain mushrooms, has been the subject of therapeutic research. While it is classified as a Schedule I substance by the Drug Enforcement Administration (DEA), suggesting it has a high potential for abuse and no medical value, there is ongoing research into its potential therapeutic benefits.

Psilocybin has been used in Mexican and Central American cultures for religious, divinatory, and spiritual purposes. It has a long history of use, with rock art from Tassili, Algeria, dating back to around 9000–7000 BCE, believed to depict psychedelic mushrooms and their effects on users.

In modern times, psilocybin is being investigated for its potential therapeutic benefits in treating various mental health disorders. The National Institute on Drug Abuse (NIDA) is researching its effectiveness in treating substance use disorders and other mental illnesses. There is also interest in its potential to treat cancer-related mental health issues, as it has been shown to reduce anxiety and depression in cancer patients and promote well-being and acceptance of their illness.

Microdosing, or taking small amounts of psilocybin regularly, is another area of interest. Some people microdose psilocybin in the hopes of improving mental health issues like depression, anxiety, and obsessive-compulsive disorder (OCD).

While the research into the therapeutic uses of psilocybin is promising, it is important to note that there are potential risks associated with its use. Psilocybin can cause disturbing hallucinations, anxiety, panic, paranoia, and even fatal events in rare cases. Additionally, there is a risk of misidentifying mushrooms and consuming poisonous ones, which can lead to accidental poisoning. Therefore, while psilocybin shows potential therapeutic benefits, more research is needed to establish its safety and efficacy.

Negative effects of hallucinogenic mushrooms

Psilocybin, the naturally occurring psychedelic found in certain types of mushrooms, can have several negative effects on users. The active ingredients in magic mushrooms are the chemicals psilocybin and psilocin, which are classified as hallucinogens. The effects of magic mushrooms usually begin within 30 minutes when eaten, or within 5–10 minutes when taken in a soup or tea, and can last approximately four to six hours.

The negative effects of magic mushrooms can vary depending on the user's mood, environment, and the dose and type of mushroom consumed. Feelings of stress or anxiety before using magic mushrooms may result in a "bad trip". A negative environment, such as a noisy or crowded place, can also contribute to a bad trip. On the other hand, being in a good state of mind, with trusted friends, and in a safe and familiar environment can reduce the risk of a bad trip.

The consumption of magic mushrooms can lead to negative physical and psychological effects. Physically, users may experience nausea, muscle twitches, increased heart rate and blood pressure, headaches, and delayed flashbacks. There have also been reports of serious harm associated with intravenous injection of mushrooms, including septic shock and multi-system organ failure.

Psychologically, users may experience an altered state of consciousness, hallucinations, and an inability to discern fantasy from reality. Panic reactions, psychosis, and heightened anxiety may also occur, particularly with larger doses. Some users may experience persistent, distressing alterations to how they see the world, known as hallucinogen-persisting perception disorder, which can manifest as flashbacks that occur anywhere from weeks to years after using the hallucinogen.

While the use of magic mushrooms rarely results in life-threatening symptoms, fatal events related to emotional distress and trip-induced psychosis have occurred in some cases due to over-consumption. Additionally, there is a risk of accidental poisoning from consuming poisonous mushrooms.

Legality of hallucinogenic mushrooms

The legality of hallucinogenic mushrooms, or psilocybin mushrooms, varies across the world. Psilocybin and psilocin, the two primary hallucinogenic toxins found in the mushrooms, are listed as Schedule I drugs under the United Nations 1971 Convention on Psychotropic Substances. Schedule I drugs are defined as drugs with a high potential for abuse or drugs that have no recognised medical uses. However, psilocybin mushrooms have been used medicinally and religiously in several cultures throughout history, and they have a significantly lower potential for abuse than other Schedule I drugs.

While the UN Convention requires its members to prohibit psilocybin, the mushrooms containing the drug were not specifically included in the convention due to pressure from the Mexican government. This has created a loophole in the legal status of psilocybin mushrooms, which are not regulated by UN treaties. As a result, the legal status of unauthorised actions with psilocybin mushrooms varies across different countries and jurisdictions.

In the United States, the use, sale, and possession of psilocybin are illegal under federal law, and it is classified as a Schedule I controlled substance. However, some states and cities have taken steps towards decriminalisation and legalisation. For example, Oregon voters passed a ballot measure in 2020 to decriminalise psilocybin and legalise its supervised use, making it the first state to do so. Other states that have followed suit include Colorado, Washington, and Massachusetts. In some jurisdictions, the spores of psilocybin mushrooms are legal to possess and sell, as they do not contain the drugs themselves. This has led to an active underground economy for the sale of spores and cultivation materials.

In other countries, such as Jamaica and Nepal, psilocybin is not explicitly mentioned in their drug control acts, effectively making it legal. Switzerland has had an exceptional use program in place since the 1980s, allowing for legal psychedelic therapy under official request. Australia has also allowed authorised psychiatrists to prescribe psilocybin for treatment-resistant depression since 2023.

The legal landscape surrounding psilocybin mushrooms is evolving as research continues to emerge on the therapeutic benefits of psychedelics for mental health conditions. However, some advocates for decriminalisation caution that more research is needed to understand the risks associated with these substances before widespread legalisation occurs.

Frequently asked questions